Antibiotic resistance dates back millions of years, with important lessons for modern medicine
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways
Antibiotics are widely considered one of the most important advances in the history of medicine. Their introduction into clinical practice during the 1940s marked a major milestone in the control of infectious diseases, and these medicines have since improved human health and prolonged life expectancy.
Today, bacterial resistance to antibiotics has become a global threat, and presents a major challenge to medicine. Antibiotics' extensive and often indiscriminate use in medicine, veterinary clinics and agriculture has created the ideal conditions for antibiotic-resistant bacteria to emerge.
However, this phenomenon is older than previously thought. Bacteria already had resistance mechanisms long before the discovery and introduction of antibiotics into clinical practice. This indicates that antibiotic resistance is a much more complex, widespread and deep-rooted ancestral evolutionary phenomenon than initially assumed.
Studies have documented antibiotic resistance mechanisms in micro-organisms isolated from natural habitats, where human influence is minimal or non-existent. These environments include deep underground layers and the ocean floor, as well as ancient environments such as isolated caves and permafrost.
Interestingly, many of the resistance mechanisms described in these untouched environments – whose origins date back thousands or even millions of years – are similar or even identical to those observed in present-day pathogenic bacteria. This suggests that the conservation and transmission of resistance mechanisms throughout evolution provides a selective advantage.
Surviving in the ice
The resistance genes found in permafrost samples from 30,000 years ago bear a striking resemblance to those found today. These strains were as resistant as more modern ones that have been observed to resist β-lactam antibiotics, tetracyclines and vancomycin.
Staphylococcus strains resistant to aminoglycosides and β-lactams have also been isolated from 3.5 million year old permafrost samples.
There are even older examples, such as Lechuguilla Cave in New Mexico, USA, an environment considered isolated for 4 million years. Nevertheless, a 2016 study found Streptomyces and Paenibacillus bacteria in Lecheguilla that were resistant to most of the antibiotics used in clinical practice today.
'Methicillin-resistant Staphylococcus aureus' is the full name for a multidrug-resistant bacterium that causes serious infections. A 2022 study concluded that certain strains were resistant long before the use of this group of antibiotics – it was their adaptation to hedgehogs infected by similar antibiotic-producing fungi that gave them a survival advantage.
An arms race to survive
Research has revealed that competition for resources and adaptation to different habitats were key factors in the evolution of antibiotic resistance.
In pre-drug environments, natural antibiotics not only played an ecological role in inhibiting the growth of competitors, but also supported the survival of producer species. In addition, very small amounts of antibiotics acted as communication molecules, influencing the interactions and balance of microbial communities.
This dynamic environment favoured the evolution of defensive strategies in antibiotic-exposed micro-organisms, whether antibiotic-producing or co-existing. This, in turn, drove the diversification and spread of resistance mechanisms over time.
However, the presence of these mechanisms in isolated, pre-antibiotic-era environments raises questions about how resistance has originated and spread throughout microbial evolution. The study of these processes is key to understanding their impact on the current antibiotic resistance crisis.
Looking forwards by looking backwards
It is now suggested that antibiotic resistance genes may have been transmitted first from environmental micro-organisms to human commensal organisms, and then to pathogens. This process of transfer from the environment to the human environment is random: the more prevalent a resistance mechanism is in the environment, the more likely it is to be transferred.
Reservoirs of resistance in the environment can accelerate bacterial evolution towards multiple drug resistance under antibiotic pressure. It is therefore crucial to consider the vast diversity of these resistance genes within microbial populations when developing or implementing new strategies to combat antibiotic resistance.
As Winston Churchill said, 'the longer you can look back, the further you can look forward'. This reflection underlines the importance of studying the past in order to understand and anticipate future risks. Researching ancestral resistance not only provides information on the evolutionary history of resistance genes, it can also help us predict how they will evolve in the future.
This knowledge allows us to anticipate potential resistance mechanisms, which improves our ability to meet future challenges in the fight against antibiotic resistance.
Este artículo fue publicado originalmente en The Conversation, un sitio de noticias sin fines de lucro dedicado a compartir ideas de expertos académicos.
Lee mas:
M. Paloma Reche Sainz receives funding from the Spanish Ministry of Science and Innovation through the National Plan PID2023-150116OB-I00, where she forms part of the research team.
Rubén Agudo Torres receives funding from the Ministry of Science and Innovation. He has previously received funding from the Spanish Ministry of Economy, Industry and Competitiveness, and the European Commission's Horizon 2020 programme.
Sergio Rius Rocabert reveices funding from the Spanish Ministry of Science and Innovation through the National Plan PID2023-150116OB-I00, where he forms part of the research team.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Scientists Find Common Kitchen Appliance May Increase Your Risk of Type 2 Diabetes
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." A new study explores the connection between exposure to 'forever chemicals' and type 2 diabetes. The man-made chemicals are already scientifically tied to cancer, thyroid disease, brain cell death, and more. Experts explain the findings and how to limit your exposure. Forever chemicals—also known as per- and polyfluoroalkyl substances, or PFAs, that don't break down, but linger in the environment and our bodies—have been linked to brain cell death, cancer, obesity, infertility, thyroid disease, and more. A new study adds type 2 diabetes to that condition list. Meet the Experts: Don Thushara Galbadage, Ph.D., M.P.H., an associate professor of public health at Texas Christian University; and Grant Fowler, M.D., chair of family medicine at the Anne Burnett Marion School of Medicine at Texas Christian University. Researchers (some of whom were compensated by pharmaceutical companies Eli Lilli and Novo Nordisk), collected health data from a small, ethnically diverse population of patients at Mount Sinai Hospital in New York. In participants' data, researchers identified PFAS exposure, metabolic disruption, and the incidence of type 2 diabetes. Below, experts explain what the findings could illuminate on a large scale. What did the study find? Put simply, the study found that people with higher levels of PFAS in their blood, which are man-made chemicals typically found in water, food packaging, and household products, showed as high as a 31% increased chance of developing type 2 diabetes, likely due to disruptions in metabolism and amino acid pathways, which are the pathways cells use to produce amino acids, 'the building blocks of proteins and regulators in metabolism,' explains Don Thushara Galbadage, Ph.D., M.P.H., an associate professor of public health at Texas Christian University. 'When PFAS disrupt these pathways, the body's ability to manage blood sugar, inflammation, and energy balance may not work properly,' he adds. 'For example, alterations in glutamate metabolism have been linked to obesity and insulin resistance, two precursors to diabetes.' How 'forever chemicals' could raise type 2 diabetes risk 'PFAS could interfere with the body's metabolism by disrupting pathways that control insulin sensitivity, amino acid balance, and fat storage,' explains Galbadage. 'Over time, these subtle shifts can increase the risk of insulin resistance, setting the stage for type 2 diabetes, even in people without traditional risk factors for diabetes.' He adds: 'Type 2 diabetes is not solely an inherited disease, but one driven by lifestyle and external factors, including environmental exposures, as this study showed. This also means that if we are able to identify these external factors and address them, it could lead to a reduced incidence of disease.' How to lower exposure to 'forever chemicals' 'By and large, we have lowered our levels of these chemicals in our blood nationally for the last few decades,' says Grant Fowler, M.D., chair of family medicine at the Anne Burnett Marion School of Medicine at Texas Christian University, 'through government regulation resulting in decreased use of these chemicals.' To lower ongoing exposure, Galbadage recommends the following habits: Use PFAS-removing water filters Replace non-stick cookware with cast iron or stainless steel Choose PFAS-free cosmetics, clothing, and cleaning products Reduce takeout food in grease-resistant packaging 'Think of it like minimizing secondhand smoke exposure. Limiting PFAS in your environment lowers your long-term risk,' he concludes. Other ways to lower type 2 diabetes risk There are studies showing that maintenance of body weight and exercising regularly, 150 minutes per week, can be effective for preventing certain types of diabetes, says Dr. Fowler. 'Any exercise is helpful,' he adds. 'It immediately lowers insulin resistance in your muscles, which helps you use less insulin and preserves your ability to produce insulin. If you are prediabetic, which can be determined by seeing your primary care provider and certain blood tests, medications can be added to your regimen of exercise and diet.' Galbadage concurs with those recommendations, and adds one: Eat a fiber-rich diet, as emerging research suggests that gel-forming fibers like oat β-glucan may help reduce blood levels of certain PFAS. Ultimately, this research 'emphasizes that diabetes prevention is not just personal—it needs to involve both health policy and environmental action,' concludes Galbadage. 'Communities with high PFAS exposure, often low-income or socioeconomically marginalized, face an unfair health burden,' he says. 'We need stronger regulations, corporate accountability, and environmental cleanup efforts. Individuals can take steps, but system-level change is essential to protect future generations.' Dr. Fowler adds that the limited size of this study warrants the need for larger studies to corroborate the findings. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword


Time Business News
13 hours ago
- Time Business News
Strepto Penicillin: History, Science, Uses, and the Future of a Life-Saving Antibiotic
The article is well researched and composed by a professional science and health writer who is also used to interpreting medical information presented in complex terms to clear and accessible language by anyone not limited to a specific background. The author has relied upon evidence-based practice since he has referred to peer-reviewed journals, literature textbooks, and reliable health organizations. The inspiration to compose this work was to enable the readers not only to acquire a technical knowledge about strepto penicillin but also have a historical and societal point of view, as it is regarded to have changed modern medicine. All the facts provided in this article have been checked cross-wise and at the end of all this checking, the reader knows that he/she is getting the best and the most updated facts. Strepto penicillin is the name that brings together two outstanding worlds of antibiotic research in science, the firstpenicillin that was found in molds and the next generation of antibiotics that is discovered in Streptomyces known as soil bacteria. Most people have heard about penicillin as the drug that transformed the field of medicine in the 20 th century but far less have heard about the significant contribution that Streptomyces species have made in the expanses of antibiotic therapy. Strepto penicillin itself is not a single drug, but an idea-one that can help span the gulf separating the fungal and bacterial esters pharmaceutical eontributions, the inspiration that brought about a pharmacopoeia of lifesaving substances. Strepto penicillin is a story quilt made of scientific discovery and industrial innovation, war-time needs, and forty years of ever-increasing research. It has a long history that intertwines with some of the most monumental events throughout the history of medicine, such as the widespread usage of antibiotics during World War II, to the advanced interventions in molecular biology popular in the 21st century. In the age of antibiotic resistance being one of the biggest challenges to the population, it would further make knowing the origins, mechanisms, and contemporary applications of strepto penicillin all the more crucial. This paper discusses the entire process, its history, structure, use, medical uses, manufacturing processes, and prospects of reducing antibiotic effectiveness in future generations with regards to the worldwide concern of retainingantibiotics usefulness to future generations. The saga of strepto penicillin started in the year 1928 when Alexander Fleming a bacteriologist of Scottish origin was something odd in his Petri dishes. In one of them, lengthening of Staphylococcus had been inhibited in the domain of one mildew community. This mold could be referred to as Penicillium notatum and it was secreting a substance that killed many bacteria but did not have any effect to human cells. It was an observation that led to the dawn of an era of the antibiotics and it would not be until over a decade later that after further research, penicillin became widely available. The Second World War saw penicillin move out of the laboratory as a curiosity into heavy industrial need as penicillin could be used in treating bacterial infections in soldiers. Production on a large scale was made possible via collaborations between the British and American scientists who improved on the fermentation process as well as discovering high yield strains of Penicillium. As the war progressed penicillin was being heralded as a miracle drug, which was saving lives which would have otherwise succumbed to infection in the likes of pneumonia, septicemia and wound infections. Although the discovery of penicillin happened in the fungal kingdom, the success of penicillin encouraged the scientists to look elsewhere in seeking other antibiotic-producing organisms. It was in this search that they went to the soil and thus found Streptomyces which is a genus of bacteria that is naturally very diverse in the formation of antimicrobial compounds. Streptomycin produced by Streptomyces griseus was one of the first and most meaningful ones and turned into the first curative agent against tuberculosis. The fact that these discoveries overlapped gives rise to the concept of a strepto penicillin. Although penicillin is not produced by Streptomyces, feats in antibiotic production, purifications, and modifications discovered in the research of streptomyces contributed to the processes of penicillin derivatives development. Such derivatives would frequently have superior stability, extended antibacterial spectra, or be able to resist attack by bacterial enzymes that would normally inactivated penicillin. The combination of both fungal-derived and Streptomyces-modelled innovation provided greatly increased amounts of antibiotics in the toolbox of doctors and hospitals all over the world. The core of strepto penicillin like analogs is the four-membered cyclic amide (the beta-lactam monomer) that is essential to the mechanism of their antibacterial agents. This ring enables connection of such bacteria enzymes as penicillin-binding proteins (PBPs) to the antibiotic. The assembly of peptidoglycan layer structure of the bacterial cell walls is due to these enzymes. Blocking of PBPs prevents the bacteria to develop a healthy cell wall thus exposing the bacteria to osmotic pressure which eventually destroys the bacteria by rupturing it. Certain derivatives of strepto penicillin have chemical alterations to the beta-lactam ring or the side chains so it can be more active against resistant bacteria, more acid stable (stomach acid) or able to penetrate the outer membranes of gram-negative bacteria. Such inventions would not have been possible without the cross-fertilisation between fungal penicillin research and the chemical creativity of streptomyces antibiotic production. Strepto penicillin mechanism is a focused biochemical attack that focuses on some of the places most basic to the life of bacteria–the cell wall. The bacteria cannot survive without this wall as it keeps the structure intact and guards them against their surroundings. Strepto penicillin attaches irreversibly to PBPs and thus blocks cross-links between chains of peptidoglycan, providing the wall with strength. In the absence of this structure, the bacteria cannot hold their shape and uphold against pressure leading to their demolishment. The mode of action is especially potent against gram-positive bacteria, which have their thick layers of peptidoglycan more exposed to the antibiotic. Nevertheless, when selected strepto penicillin derivatives are carefully chemically modified, they can also attack gram-negative bacteria, which have an outer membrane in addition to that of gram-positive bacteria, and can frequently exclude antibiotics. Strepto penicillin is widely used medically and its applications include a very wide array of bacterial diseases. It is administered in respiratory medicine as a cure against pneumonia and bronchitis wrought by vulnerable bacteria. Dermatologically it is used in skin and soft tissue infections, such as cellulitis and erysipelas. The disease is used in cardiology to prevent or treat bacterial endocarditis, and in neurology it is used in the management of bacterial meningitis using certain formulations. In addition to these, strepto penicillin may also form the basis of combination therapy as a strategy to combat other infections which might be caused by multi-drug resistant bacteria. It also has a place in operative treatment where it is used as a prophylactic measure and aids in minimizing the danger of postsurgical infections. This stability and adaptability of this family of antibiotics have contributed to its use as a foundation of how infectious diseases are treated today. Although its importance is both historical and up to date, strepto penicillin, like all antibiotics, is exposed to the same issue as bacteria are resistant to it. Some bacteria have developed defense mechanisms after decades of exposure with the most widespread being the creation of beta-lactamases the enzymes that cleave through the beta-lactam ring making the antibiotic useless. PBPs of other bacteria have changed to prevent the antibiotic to bind successfully. To solve these problems, pharmaceutical researchers invented beta-lactamase inhibitor, where beta-lactamase can be used together with strepto penicillin to ensure protection against enzyme degradation. Nevertheless, these measures have their limits, too, and new resistance systems still appear. That is why it is crucial to use antibiotics wisely as a method of antibiotic stewardship and make their use based on the real necessity only, in order to maintain their effectiveness. Industrial scale production of strepto penicillin is a mix of microbiological growth, chemical engineering and pharmaceutical processing. The first step of this process would involve developing either Penicillium or Streptomyces strain in a controlled fermentation environment that would result in the production of antibiotic substances. After the fermentation interacting with the culture broth, the antibiotic is isolated, and is stripped off impurities and is then modified chemically in case of need to form certain derivatives. Genetic engineering is becoming a large part of most modern pharmaceutical plants, which makes them well equipped to optimize their production strain, giving them an increased yield and a more predictable chemistry. This guarantees that the end product drug has high standards of quality and safety before being availed at hospitals and pharmacies. The future of strepto penicillin will have to rely on both innovation and responsibilities. Regarding practical innovation, scientists are working on synthetic biology to come up new structures of beta-lactams which the bacteria will have never seen. It has the potential to develop antibiotics that will go round current resistance systems. Targeted delivery systems Another area of possible discovery is so-called nanoparticle carriers; this is where strepto penicillin is transported to the infection site so it has a maximum effect and a minimum impact on beneficial bacteria in the body. In its side of responsibility the global health organizations are insisting on rigid use of antibiotic stewardship. This implies not only prescribing strepto penicillin and analog drugs sparingly but also training the society on full antibiotics satisfaction and prevention of overuse of the medication. It is only through the scaling back of sharp science and considerate utilization that we can be sure reaching into the future that strepto penicillin will continue to be effective in curbing bacterial infections. Strepto penicillin itself is not an individual or isolated medication but is a classification that can be used to describe derivatives of penicillin affected by or synthesized using techniques based on the Streptomyces bacteria bacteria. It totals the foundation of the classical production of penicillin with the advancements that came with the observation about other antibiotics producing microorganisms. Most regular penicillin is derived from Penicillium mold, but strepto penicillin derivatives can be developed as a mutant with increased stability, or wider antibacterial activity, or resistance to bacterial enzymes. These advances commonly are based upon chemical tactics initially discovered in the analysis of antibiotics created by Streptomyces. No, it is not able to cure all kinds of bacterial infections. It works on the premise of the infection causing bacteria being vulnerable to the medicine. Other infections and in particular the ones caused by resistant gram-negative bacteria might necessitate the use of antibiotics of other classes altogether. Strepto penicillin, as all antibiotics, may have a side effect. These can be anything as mild as nausea, diarrhea, rashes and include serious cases of allergies in others. Anaphylaxis is quite a serious medical condition that needs prompt treatment, albeit rarely. The prevalence of strepto penicillin antibiotic resistance is one of the limiting factors to the use of strepto penicillin freely in many situations. Resistant bacteria degrade the drug using enzymes or change the proteins they use to make up their cell walls in such a way that the antibiotic cannot attach itself to them. This makes it very important that one takes antibiotics responsibly and only under the professional advice. It is quite safe to use strepto penicillin during pregnancy in most incidence but a health practitioner should always decide whether to use it or not after comparing the risks and the benefits involved. The safety may also depend on a specific formulation and the health of a patient. Strepto penicillin is the product of medical innovation blending both the older success story of penicillin and the new opportunities with new discoveries about Streptomyces. It has already helped to save numerous lives and remains one of the pillars that helps in fighting against bacterial infections. Nevertheless, the increasing issue of antibiotic resistance acts as a constant reminder of the fact that this weapon has to be used sparingly. With further science, the tale of strepto penicillin will keep developing itself through the dualism of innovation and stewardship. Formulation of new derivatives, utilization of novel delivery techniques and mobilization of healthcare providers and general population to adhere to prudent use can help ensure that this spectacular antibiotic sustains its life-saving potential into generations to come. Not only in hospitals and clinics has strepto penicillin left a mark but also as a greater achievement of mankind in comprehending and utilizing the chemistry of nature to the good of the society. It warns us not to be surprised where the solutions to some of the world most health complications might be found; whether it is a mold growing on an unused Petri dish or a bacteria growing in the ground. Much still needs to be done to fight the diseases that are infectious, yet strepto penicillin, with furthers research and responsible distribution and collaboration of global health care options, will continue as an ally in human health protection for generations to come. TIME BUSINESS NEWS
Yahoo
16 hours ago
- Yahoo
How to Watch All of the ‘Alien' Movies in Release & Chronological Order
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." With Alien: Earth, a new FX series from creator Noah Hawley, comes the perfect excuse to watch all of the movies from the series that brought us Ellen Ripley, the Xenomorph, David the android, and a whole lot of deep space thrills and chills from some pretty impressive directors. To make it easier for you than any of the poor souls in these movies have it at any given time, here's what you need to know to watch the Alien movies in order. Before we get started: there was also a time in the naughty aughties when the, err, alien species from Alien made an co-starring appearance in two crossover movies: 2004's Alien vs. Predator and 2007's Aliens vs. Predator: Requiem. As far as I'm concerned, those movies are extra credit. If you're super invested in the extraterrestrial part of Alien, feel free to slot those babies in between 1997's Alien: Resurrection and 2012's Prometheus. Try to fight the urge to then, ofc, watch all of the Predator movies, including the 2022 Amber Midthunder vehicle Prey, and 2025's Predator: Badlands. Why so many movies!?!! Without further ado, here are the Alien (no Predator allowed) movies in release order: Alien (1979) The first movie, directed by Ridley Scott, follows a crew of scientists who work for a company called Weyland-Yutani and answer what they think is a distress call from a planet on the way home to Earth. They inadvertently bring a deadly alien called a "xenomorph" back with them and have to fight the creature, company policy, and their own inability to listen to women (Ellen Ripley, played by Sigourney Weaver) in order to survive. Despite the title and the setting, the O.G. Alien is actually more of a horror movie than a science fiction movie. It's essentially structured like a classic slasher flick, but instead of a haunted house or a cabin in the woods the people a mysterious killer is picking off, one by one until only the final girl is left, are on a spaceship. Shop Now Aliens (1986) Many fans of the franchise, or of movies in general, prefer director James Cameron's sequel. It turns Ripley from a final girl into a full action heroine–but men still don't listen to her! Five decades after the first movie, Weyland-Yutani wakes Ripley up from cryostasis to ask for her help with the moon where she and her crew first encountered a xenomorph, because the company now want to terraform it and lost contact with the colonizers. When they land, they find only one survivor: a girl named Newt. Thankfully, this Ripley at least is backed by the military, instead of scientists and an evil corporate robot more concerned with following orders than human lives. Her compadres are as willing to kill the aliens as she is, which must help with the trauma. Some even survive! Shop Now Alien³ (1992) The third movie in the franchise also happens to be directed by a third major director: David Fincher, known best for Se7en, Fight Club, Gone Girl, and The Social Network. This is actually his first feature film. Alien 3 takes place immediately after Aliens as Ripley and [redacted] other survivors escape the moon. Will she finally catch a break, or at least a chance to process everything she has experienced? Absolutely not. She crash lands, with a stray xenomorph still on board her ship, onto a prison planet that does not even allow the guards to have weapons. They're angry, isolated, and totally defenseless. Talk about upping the stakes! Shop Now Alien: Resurrection (1997) Winona Ryder is in this one! This film is set 200 years after Alien 3, when Ripley is long dead. The title Resurrection, however, should give you a clue as to what happens next. Military scientists in the future clone Weaver's character and a xenomorph for study. Thanks to an experiment gone wrong, a group of mercenaries, and an unexpected glitch in the cloning process, a battle ensues as Ripley gets closer to Earth than ever before. Weaver was a co-producer on the movie and Joss Whedon wrote the screenplay. Director Jean-Pierre Jeunet followed this up with Amélie in 2001. Isn't that, to use some classic late 00s slang, so random? Shop Now Prometheus (2012) After the brief AVP duology/diversion, the Alien movies did what so many franchises tend to do: back it up. Prometheus is a prequel directed by Ridley Scott in a return to the IP. It takes place in 2089 and follows a crew commissioned by the founder and CEO of the Weyland Corporation played by Guy Pearce, and lead by an archaeologist played by Noomi Rapace, an early android named David played by Michael Fassbender, the captain played by Idris Elba, a corporate stiff played by Charlize Theron, and a cool scientist played by Logan Marshall-Green. What they find when they get where they're going is a major lore drop, Alien wise. Shop Now Alien: Covenant (2017) The 2017 movie is infamous for Fassbender making out with himself. (It seems silly to say given everything that has happened since, but we needed something to smile about in 2017.) It follows a colonist ship in 2104 that answers a transmission from a mysterious, uncharted planet where David and the survivors of Prometheus landed between films. A lot of the action takes place on land in a jungle–a little like Alien meets Jurassic Park. (Just a little, though. Let's not be crazy! Xenomorphs make raptors look like puppies.) Shop Now Alien: Romulus (2024) This spin-off, directed by Fede Álvarez, is set between Alien and Aliens while Ellen is taking a cryo nap. It got back to basics with a new haunted house story featuring Cailee Spaeny, David Jonsson, Archie Renaux, Isabela Merced, Spike Fearn, and Aileen Wu as potential victims. Their characters, space colonists (again) running away from their home and contracts to make a new life for themselves on a new planet free from Weyland-Yutani, sneak onto a space station called Romulus to steal cryostasis equipment. Unfortunately for them, a cocoon containing a xenomorph (as well as a lot of unhatched eggs) recovered from theAlien spaceship happens to be in storage on the Romulus. Shop Now Prometheus Alien: Covenant Alien Alien: Romulus Aliens Alien³ Alien: Resurrection Want to follow the ongoing story of a f*cked up world from beginning to end? The new FX series Alien: Earth is set one year before the events of Alien. As we mentioned above, movies like Prometheus, Alien: Covenant and Alien: Romulus are prequels to the original movies in the franchise. So, in planning your Alien marathon, it might be smart to watch these in "story" order a.k.a. "timeline" order or chronological order instead of the order they came out. Again, for extra credit, you can also include Alien vs. Predator and Aliens vs. Predator: Requiem in the saga. If you do, start with them because they take place, like, waaaaaay before Prometheus even in 2004. They're basically period pieces You Might Also Like Here's What NOT to Wear to a Wedding Meet the Laziest, Easiest Acne Routine You'll Ever Try Solve the daily Crossword